Antiviral activity against Tick-borne encephalitis virus Absettarov infected in PEK cells assessed as reduction in viral plaque formation incubated for 1 hr measured after 6 days by gentian violet staining
Antiviral activity against Tick-borne encephalitis virus Absettarov infected in PEK cells assessed as reduction in viral plaque formation compounds preincubated with cells for 1 hr followed by addition of virus with subsequent incubation of 1 hr by gentian violet staining
Antiviral activity against Tick-borne encephalitis virus Absettarov infected in PEK cells assessed as reduction in viral plaque formation compounds preincubated with virus for 1 hr followed by addition of cells with subsequent incubation of 1 hr measured after 6 days by gentian violet staining
Antiviral activity against 2 PFU Tick-borne encephalitis virus Absettarov infected in PEK cells assessed as inhibition of viral titer at 200 EC50 for simultaneous addition of compound/cells/virus incubated for 1 hr measured after 6 days by gentian violet staining
Antiviral activity against 22 PFU Tick-borne encephalitis virus Absettarov infected in PEK cells assessed as inhibition of viral titer at 200 EC50 for simultaneous addition of compound/cells/virus incubated for 1 hr measured after 6 days by gentian violet staining
Antiviral activity against 2.2x10'2 PFU Tick-borne encephalitis virus Absettarov infected in PEK cells assessed as inhibition of viral titer at 200 EC50 for simultaneous addition of compound/cells/virus incubated for 1 hr measured after 6 days by gentian violet staining
Antiviral activity against 2.2x10'3 PFU Tick-borne encephalitis virus Absettarov infected in PEK cells assessed as inhibition of viral titer at 200 EC50 for simultaneous addition of compound/cells/virus incubated for 1 hr measured after 6 days by gentian violet staining
Antiviral activity against 2.2x10'4 PFU Tick-borne encephalitis virus Absettarov infected in PEK cells assessed as inhibition of viral titer at 200 EC50 for simultaneous addition of compound/cells/virus incubated for 1 hr measured after 6 days by gentian violet staining
Antiviral activity against 2.2x10'5 PFU Tick-borne encephalitis virus Absettarov infected in PEK cells assessed as inhibition of viral titer at 200 EC50 for simultaneous addition of compound/cells/virus incubated for 1 hr measured after 6 days by gentian violet staining
Antiviral activity against HSV1 KOS infected in African green monkey Vero cells treated for 10 mins measured after 1 to 2 days by crystal violet staining-based assay
Antiviral activity against HSV2 186 infected in African green monkey Vero cells treated for 10 mins measured after 1 to 2 days by crystal violet staining-based assay
Antiviral activity against VSV infected in African green monkey Vero cells treated for 10 mins measured after 1 to 2 days by crystal violet staining-based assay
Antiviral activity against Sindbis virus infected in African green monkey Vero cells treated for 10 mins measured after 1 to 2 days by crystal violet staining-based assay
Antiviral activity against Influenza virus A/PR/8/34 (H1N1) infected in MDCK cells treated for 10 mins measured after 1 hr by neutral red or crystal violet staining-based assay
Antiviral activity against Influenza virus A/USSR/90/77 (H1N1) infected in MDCK cells treated for 10 mins measured after 1 hr by neutral red or crystal violet staining-based assay
Antiviral activity against Influenza virus A/Aichi/2/68 (H3N2) infected in MDCK cells treated for 10 mins measured after 1 hr by neutral red or crystal violet staining-based assay